Infinite Auctions' Blockbuster LeBron James Finals jersey sale and Real Game Used's authentication revenues strengthen MDCE's balance sheet and support AI-powered healthcare application development.
Read More
- Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients -
- Gemini could potentially revolutionize the treatment of acute and chronic inflammatory disease -
Data discussion webcast/conference call will be held at 8:30 am Eastern Time
Read More
Sublimation Health has been recognized in the KLAS Emerging Company Spotlight Report, an independent evaluation based on direct provider feedback. Customers rated Sublimation Health among the very best in the industry, giving the company consistent A+ ratings that reflect its ability to deliver resilient environments, cost clarity, and meaningful cloud outcomes.
Read More
Following new safety concerns from the U.S. Food and Drug Administration (FDA) regarding benzoyl peroxide (BPO) acne products, CLn Skin Care is launching an education and awareness campaign to inform both physicians and consumers of safer alternatives for acne management. In its March 2024 safety communication, the FDA revealed that approximately 10% of benzoyl peroxide acne products tested showed elevated levels of benzene, a known human carcinogen.¹
Read More
Launch timetable is now imminent for developers of a revolutionary system for medication management as they open an initial SAFE investment round and will fund final product development and market validation in compelling use-case.
Read MoreNew preclinical findings highlight Telomir-1's ability to reverse CDKN2A gene silencing by DNA methylation, reactivating this gene - often called the body's natural "cell cycle brake." These results build on prior STAT1 data, supporting Telomir-1's profile as a potential first-in-class broad-spectrum DNA methylation reset therapy.
Read More
- Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients -
- Gemini could potentially revolutionize the treatment of acute and chronic inflammatory disease -
Data discussion webcast/conference call will be held on Wednesday, September 10th at 8:30 am Eastern Time
Read More- CID-103 is a potential best-in-class, clinical stage anti-CD38 monoclonal antibody
- Safety profile observed in first four dose cohorts supports continued development
- No serious adverse events or dose-limiting toxicities have been reported
Read More
· Research focused on long-acting therapeutics based on Remedium's proprietary Prometheus™ platform
· Multiple targets for the treatment of Obesity and Type 2 Diabetes
Read More
Is the DEA the Epitome of Ineptitude?
"Why is the VA importing cannabis that U.S. companies have been ready to produce for years? If American cannabis is ‘too dangerous' for research, why is foreign cannabis treatment suddenly acceptable for our veterans?" asked Duane Boise, CEO of MMJ International Holdings.
Read More
